Showing results (251-260 of 279) with videos related to

Sort By:
Pageof 28
BMC Cancer|June 23, 2010
Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinomaLaura M S Seeber, Nicole Horrée, Petra van der Groep, et al.
Breast (Edinburgh, Scotland)|March 2, 2019
Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA studyA Mavratzas, S Baek, B Gerber, et al.
Cancer Research|June 13, 2000
Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expressionN S Werner, Z Siprashvili, L Y Fong, et al.
The Journal of Infusional Chemotherapy|July 1, 1996
Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancerH Wilke, M Korn, U Vanhöfer, et al.
Annals of Hematology|December 2, 2000
Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemiaM Flasshove, P Meusers, J Schütte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2010
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trialG von Minckwitz, H Eidtmann, S Loibl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalitiesM Sarbia, M Stahl, A zur Hausen, et al.
Genes, Chromosomes & Cancer|October 1, 1996
Detection of chromosomal DNA gains and losses in testicular germ cell tumors by comparative genomic hybridizationW M Korn, D E Oide Weghuis, R F Suijkerbuijk, et al.
Critical Reviews in Oncology/Hematology|July 15, 2010
The role of hypoxia inducible factor-1alpha in gynecological cancerLaura M S Seeber, Nicole Horrée, Marc A G G Vooijs, et al.
European Journal of Haematology|December 23, 2004
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myelomaP Schütt, P Ebeling, U Buttkereit, et al.
Pageof 28